2012-01-09T09:18:20Z
2012-01-09T09:18:20Z
2011
2011-12-27T14:10:22Z
Podeu consultar el llibre complet a: http://www.trnres.com/ebookcontents.php?id=149
The aim of this work was to design a novel strategy to detect new targets for anticancer treatments. The rationale was to build Biological Association Networks from differentially expressed genes in drug-resistant cells to identify important nodes within the Networks. These nodes may represent putative targets to attack in cancer therapy, as a way to destabilize the gene network developed by the resistant cells to escape from the drug pressure. As a model we used cells resistant to methotrexate (MTX), an inhibitor of DHFR. Selected node-genes were analyzed at the transcriptional level and from a genotypic point of view. In colon cancer cells, DHFR, the AKR1 family, PKC¿, S100A4, DKK1, and CAV1 were overexpressed while E-cadherin was lost. In breast cancer cells, the UGT1A family was overexpressed, whereas EEF1A1 was overexpressed in pancreatic cells. Interference RNAs directed against these targets sensitized cells towards MTX.
Capítol o part de llibre
Versió publicada
Anglès
Càncer; Quimioteràpia; Farmacogenètica; Cancer; Chemotherapy; Pharmacogenetics
Transworld Research Network
Reproducció del capítol 1 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=106
Recent Advances in Pharmaceutical Sciences, 2011, Chapter 1, p. 1-33. Editor: Diego Muñoz-Torrero
http://hdl.handle.net/2445/32392
(c) Transworld Research Network, 2011